HROW Harrow, Inc.

NASDAQ
$29.09

Harrow, Inc. (HROW) is expected to report earnings on February 8, 2027, after the market close. The consensus earnings estimate is $0.56 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -12.0% since its last earnings release on November 9, 2026.

Harrow Missed Consensus Estimates, Reaffirms
Monday, November 9, 2026 · 4:02 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 8
Monday · 4:05 PM ET
Earnings Whisper
-
vs $0.56
Rev est $136.57M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $29.77

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Harrow, Inc.

Harrow Health, Inc. is an ophthalmic-focused healthcare company.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Charts powered in part by Lightweight Charts™ by TradingView.